183 related articles for article (PubMed ID: 24458973)
21. EGPI-1, a novel eIF4E/eIF4G interaction inhibitor, inhibits lung cancer cell growth and angiogenesis through Ras/MNK/ERK/eIF4E signaling pathway.
Qi X; Zhang S; Chen Z; Wang L; Zhu W; Yin C; Fan J; Wu X; Wang J; Guo C
Chem Biol Interact; 2022 Jan; 352():109773. PubMed ID: 34902296
[TBL] [Abstract][Full Text] [Related]
22. Structure of eIF4E in Complex with an eIF4G Peptide Supports a Universal Bipartite Binding Mode for Protein Translation.
Miras M; Truniger V; Silva C; Verdaguer N; Aranda MA; Querol-Audí J
Plant Physiol; 2017 Jul; 174(3):1476-1491. PubMed ID: 28522457
[TBL] [Abstract][Full Text] [Related]
23. eIF4E-eIF4G complex inhibition synergistically enhances the effect of sorafenib in hepatocellular carcinoma.
Fang C; Xie H; Zhao J; Wang W; Hou H; Zhang B; Zhou D; Geng X
Anticancer Drugs; 2021 Sep; 32(8):822-828. PubMed ID: 33783376
[TBL] [Abstract][Full Text] [Related]
24. Requirement of Mammalian target of rapamycin complex 1 downstream effectors in cued fear memory reconsolidation and its persistence.
Huynh TN; Santini E; Klann E
J Neurosci; 2014 Jul; 34(27):9034-9. PubMed ID: 24990923
[TBL] [Abstract][Full Text] [Related]
25. 4EGI-1 induces apoptosis and enhances radiotherapy sensitivity in nasopharyngeal carcinoma cells via DR5 induction on 4E-BP1 dephosphorylation.
Wang W; Li J; Wen Q; Luo J; Chu S; Chen L; Qing Z; Xie G; Xu L; Alnemah MM; Li M; Fan S; Zhang H
Oncotarget; 2016 Apr; 7(16):21728-41. PubMed ID: 26942880
[TBL] [Abstract][Full Text] [Related]
26.
Sekiyama N; Boeszoermenyi A; Arthanari H; Wagner G; Léger-Abraham M
Biomol NMR Assign; 2017 Oct; 11(2):187-191. PubMed ID: 28589219
[TBL] [Abstract][Full Text] [Related]
27. A biphenyl inhibitor of eIF4E targeting an internal binding site enables the design of cell-permeable PROTAC-degraders.
Fischer PD; Papadopoulos E; Dempersmier JM; Wang ZF; Nowak RP; Donovan KA; Kalabathula J; Gorgulla C; Junghanns PPM; Kabha E; Dimitrakakis N; Petrov OI; Mitsiades C; Ducho C; Gelev V; Fischer ES; Wagner G; Arthanari H
Eur J Med Chem; 2021 Jul; 219():113435. PubMed ID: 33892272
[TBL] [Abstract][Full Text] [Related]
28. Eukaryotic translation initiation factor 4G (eIF4G) coordinates interactions with eIF4A, eIF4B, and eIF4E in binding and translation of the barley yellow dwarf virus 3' cap-independent translation element (BTE).
Zhao P; Liu Q; Miller WA; Goss DJ
J Biol Chem; 2017 Apr; 292(14):5921-5931. PubMed ID: 28242763
[TBL] [Abstract][Full Text] [Related]
29. Identification and function of the second eIF4E-binding region in N-terminal domain of eIF4G: comparison with eIF4E-binding protein.
Umenaga Y; Paku KS; In Y; Ishida T; Tomoo K
Biochem Biophys Res Commun; 2011 Oct; 414(3):462-7. PubMed ID: 21964297
[TBL] [Abstract][Full Text] [Related]
30. Inhibition of the interactions between eukaryotic initiation factors 4E and 4G impairs long-term associative memory consolidation but not reconsolidation.
Hoeffer CA; Cowansage KK; Arnold EC; Banko JL; Moerke NJ; Rodriguez R; Schmidt EK; Klosi E; Chorev M; Lloyd RE; Pierre P; Wagner G; LeDoux JE; Klann E
Proc Natl Acad Sci U S A; 2011 Feb; 108(8):3383-8. PubMed ID: 21289279
[TBL] [Abstract][Full Text] [Related]
31. Regulation of eukaryotic initiation factor 4E (eIF4E) phosphorylation by mitogen-activated protein kinase occurs through modulation of Mnk1-eIF4G interaction.
Shveygert M; Kaiser C; Bradrick SS; Gromeier M
Mol Cell Biol; 2010 Nov; 30(21):5160-7. PubMed ID: 20823271
[TBL] [Abstract][Full Text] [Related]
32. Inhibition of ovarian cancer growth by a tumor-targeting peptide that binds eukaryotic translation initiation factor 4E.
Ko SY; Guo H; Barengo N; Naora H
Clin Cancer Res; 2009 Jul; 15(13):4336-47. PubMed ID: 19458052
[TBL] [Abstract][Full Text] [Related]
33. A microtiter plate assay for assessing the interaction of eukaryotic initiation factor eIF4E with eIF4G and eIF4E binding protein-1.
Kimball SR; Horetsky RL; Jefferson LS
Anal Biochem; 2004 Feb; 325(2):364-8. PubMed ID: 14751272
[TBL] [Abstract][Full Text] [Related]
34. Structural basis for competitive inhibition of eIF4G-Mnk1 interaction by the adenovirus 100-kilodalton protein.
Cuesta R; Xi Q; Schneider RJ
J Virol; 2004 Jul; 78(14):7707-16. PubMed ID: 15220445
[TBL] [Abstract][Full Text] [Related]
35. The cap-translation inhibitor 4EGI-1 induces mitochondrial dysfunction via regulation of mitochondrial dynamic proteins in human glioma U251 cells.
Yang X; Dong QF; Li LW; Huo JL; Li PQ; Fei Z; Zhen HN
Neurochem Int; 2015 Nov; 90():98-106. PubMed ID: 26220902
[TBL] [Abstract][Full Text] [Related]
36. Novel eIF4E/eIF4G protein-protein interaction inhibitors DDH-1 exhibits anti-cancer activity in vivo and in vitro.
Wang J; Wang L; Zhang S; Fan J; Yang H; Li Q; Guo C
Int J Biol Macromol; 2020 Oct; 160():496-505. PubMed ID: 32479946
[TBL] [Abstract][Full Text] [Related]
37. Translation initiation factors GleIF4E2 and GleIF4A can interact directly with the components of the pre-initiation complex to facilitate translation initiation in Giardia lamblia.
Adedoja AN; McMahan T; Neal JP; Hamal Dhakal S; Jois S; Romo D; Hull K; Garlapati S
Mol Biochem Parasitol; 2020 Mar; 236():111258. PubMed ID: 31968220
[TBL] [Abstract][Full Text] [Related]
38. Molecular dynamics simulations revealed topological frustration in the binding-wrapping process of eIF4G with eIF4E.
Gao M; Huang Y
Phys Chem Chem Phys; 2024 Jan; 26(3):2073-2081. PubMed ID: 38131207
[TBL] [Abstract][Full Text] [Related]
39. A mutant of eukaryotic protein synthesis initiation factor eIF4E(K119A) has an increased binding affinity for both m7G cap analogues and eIF4G peptides.
Friedland DE; Wooten WN; LaVoy JE; Hagedorn CH; Goss DJ
Biochemistry; 2005 Mar; 44(11):4546-50. PubMed ID: 15766285
[TBL] [Abstract][Full Text] [Related]
40. Evaluating the conformation and binding interface of cap-binding proteins and complexes via ultraviolet photodissociation mass spectrometry.
O'Brien JP; Mayberry LK; Murphy PA; Browning KS; Brodbelt JS
J Proteome Res; 2013 Dec; 12(12):5867-77. PubMed ID: 24200290
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
